Sutro Biopharma STRO Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's free cash flow?
- Sutro Biopharma (STRO) reported free cash flow of -$42.26M in Q1 2026.
- How has Sutro Biopharma's free cash flow changed year-over-year?
- Sutro Biopharma's free cash flow increased by 37.8% year-over-year, from -$67.91M to -$42.26M.
- What is the long-term trend for Sutro Biopharma's free cash flow?
- Over 2 years (2021 to 2025), Sutro Biopharma's free cash flow has grown at a 47.0% compound annual growth rate (CAGR), from -$82.05M to -$177.24M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.